SFDA- “Guideline on Requirements for Advertising and Promotion of Pharmaceutical and Herbal Products” V 7.0
The Saudi Food & Drug Authority (“SFDA”) has issued V 7.0 of
Regulinked
- January 27, 2026
- Guideline
- No Comments
Tag: SFDA
CMC Guidance for Human Gene Therapy Clinical Trial Applications
SFDA Issues Final CMC Guidance for Human Gene Therapy Clinical Trial Applications.
- November 7, 2025
- Consulting
- No Comments
SFDA- “Verification & Abridged Pathways” Guideline updates
SFDA issues updated “Verification & Abridged Pathways” Guideline (Version 3.0 — Issued
- October 31, 2025
- Acceleration process
- No Comments
SFDA- Approach of Dealing with Patents When Registering Generic Drugs in SFDA Guideline
The Saudi Food & Drug Authority (“SFDA”) has issued a new guidance
- October 23, 2025
- Guideline
- No Comments
SFDA issues “Good Review Practices (GRevPs)” Guideline Version 1.0
SFDA issues “Good Review Practices (GRevPs)” Guideline Version 1.0 🔍 What’s new:
- October 3, 2025
- Guideline
- No Comments
SFDA updates – Guideline of Data Requirements for Human Drug Submissions – Version 4.0
SFDA publishes Version 4.0 of Data Requirements for Human Drug Submissions (August
- September 14, 2025
- Guideline
- No Comments
SFDA updates – Guideline on Good Pharmacovigilance Practices (GVP)
SFDA Just publish new updates regarding Guideline on Good Pharmacovigilance Practices (GVP)
- September 12, 2025
- Guideline
- No Comments
ReguLinked Consulting helps pharmaceutical, healthcare, and life sciences companies achieve seamless market access and regulatory compliance across Saudi Arabia and the GCC. Trusted expertise. Local insight. Real results.